Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-21-015072

Director acquired 61,800 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KINGSLEY ALFRED D · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-06-22 Exercise or conversion : show line 1 in the form +61,800 $2.20 $135,960 5,470,245 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-06-22 Exercise or conversion : show line 2 in the form Stock Option (right to buy) −61,800 0 D
Loading xslF345X03/ownership.xml…